Atrial fibrillation in patients with diabetes and renal impairment

Declaration of consent *
By your signature, you hereby authorize Bayer AG (hereinafter “us”, “our” or “we”) as well as other Bayer affiliates involved in managing a service or communication towards you, to directly deliver marketing/medical communications to you through e-mails or other electronic communications containing information about services, products or events related to your medical interest (“Electronic Marketing/Medical Communications”) as well as via phone calls and to analyze your use of our Electronic Marketing/Medical Communications in order to enable a customization of Electronic Marketing/Medical Communications to meet your needs and preferences as described in the information on data privacy.
You are free to revoke your consent at any time with future effect. Please address your declaration of revocation to the contact described in the information on data privacy. Furthermore, every Electronic Marketing/Medical Communication we send to you includes an option for you to easily revoke your consent by clicking an unsubscribe link.